Dashboard
Manage Tickers

AKYA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 17:06:51

Core News & Articles
Kent Lake Raises Concerns Over Quanterix's...
05/23/2025 18:27:58

Kent Lake PR LLC ("Kent Lake"), a holder of approximately 6.9% of the outstanding common stock of Quanterix Corporation...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
05/21/2025 17:06:44

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
05/21/2025 12:07:32

Core News & Articles
Akoya Announced Receipt Of Unsolicited Pro...
05/21/2025 10:06:22

https://www.sec.gov/ix?doc=/Archives/edgar/data/1711933/000155837025008039/akya-20250520x8k.htm

canaccord-genuity-maintains-hold-on-akoya-biosciences-lowers-price-target-to-108
Canaccord Genuity Maintains Hold on Akoya ...
05/19/2025 15:13:55

Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:AKYA) with a Hold and lowers the price target from...

akoya-biosciences-q1-eps-032-misses-020-estimate-sales-1664m-miss-1995m-estimate
Akoya Biosciences Q1 EPS $(0.32) Misses $(...
05/12/2025 20:43:01

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $...

Core News & Articles
Quanterix To Issue About 7.76M Shares, Pay...
04/29/2025 11:21:59

Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of CombinationQuanterix Corporation (NASDAQ:QTRX...

akoya-biosciences-and-enable-medicine-collaborate-to-deliver-single-cell-spatial-proteomics-atlas
Akoya Biosciences And Enable Medicine Coll...
04/24/2025 12:02:12

akoya-biosciences-expands-portfolio-with-adc-breast-cancer-assay-and-real-world-io60-insights-at-aacr-2025
Akoya Biosciences Expands Portfolio With A...
04/24/2025 12:01:28

Core News & Articles
Kent Lake, A 7.7% Shareholder Of Quanterix...
04/17/2025 12:38:38

Urges Shareholders to Vote AGAINST Both Proposals Related to the Value-Destructive Merger with Akoya at the Upcoming Special Me...

piper-sandler-maintains-neutral-on-akoya-biosciences-lowers-price-target-to-165
Piper Sandler Maintains Neutral on Akoya B...
04/14/2025 14:55:23

Piper Sandler analyst David Westenberg maintains Akoya Biosciences (NASDAQ:AKYA) with a Neutral and lowers the price target ...

Core News & Articles
Tikvah Management Calls On Quanterix To Ex...
04/14/2025 12:05:04

Tikvah Management LLC (together with its affiliates, "Tikvah" or "we"), which owns approximately 1.5% of the ou...

akoya-biosciences-and-team-sambai-select-phenocycler-fusion-as-foundational-spatial-proteomics-technology-for-large-scale-study-to-address-cancer-inequities
Akoya Biosciences And Team SAMBAI Select P...
04/02/2025 12:23:00

Akoya's technology to generate data for a first-of-its-kind Biobank and Data Repository for Cancer Equity Research, funded ...

this-brown--brown-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday
This Brown & Brown Analyst Is No Longer Bu...
03/25/2025 14:57:05

stephens--co-downgrades-akoya-biosciences-to-equal-weight-lowers-price-target-to-18
Stephens & Co. Downgrades Akoya Bioscience...
03/25/2025 14:32:22

Stephens & Co. analyst Mason Carrico downgrades Akoya Biosciences (NASDAQ:AKYA) from Overweight to Equal-Weight and lowe...

stephens--co-reiterates-overweight-on-akoya-biosciences-maintains-35-price-target
Stephens & Co. Reiterates Overweight on Ak...
03/18/2025 13:40:10

Stephens & Co. analyst Mason Carrico reiterates Akoya Biosciences (NASDAQ:AKYA) with a Overweight and maintains $3.5 pri...

Core News & Articles
Kent Lake Urges Quanterix Management To Ad...
03/17/2025 20:09:09

Believes Proposed Transaction with Akoya Significantly Undervalues QuanterixEncourages Shareholders to Vote Against Transaction...

akoya-biosciences-q4-2024-gaap-eps-017-misses-016-estimate-sales-21344m-beat-21338m-estimate
Akoya Biosciences Q4 2024 GAAP EPS $(0.17)...
03/17/2025 20:03:38

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $...

Core News & Articles
Kent Lake Issues Letter To Quanterix Share...
02/18/2025 20:42:52

Believes Merger Agreement Significantly Undervalues QuanterixKent Lake PR LLC ("Kent Lake"), a holder of 5.9% of the ou...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION